Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-18), CanAlaska Uranium's 1-Year Sharpe Ratio is -0.76.
CanAlaska Uranium (FRA:DH7) 1-Year Sharpe Ratio Explanation
The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.
The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.
CanAlaska Uranium 1-Year Sharpe Ratio Related Terms
CanAlaska Uranium 1-Year Sharpe Ratio Competitor Comparison
For the Other Industrial Metals & Mining subindustry, CanAlaska Uranium's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CanAlaska Uranium 1-Year Sharpe Ratio vs Metals & Mining Industry
For the Metals & Mining industry and Basic Materials sector, CanAlaska Uranium's 1-Year Sharpe Ratio distribution charts can be found below:
* The bar in red indicates where CanAlaska Uranium's 1-Year Sharpe Ratio falls into.
The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.
CanAlaska Uranium (FRA:DH7) has a 1-Year Sharpe Ratio of -0.76 as of Aug. 18, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for CanAlaska Uranium and its competitors.
Is CanAlaska Uranium's 1-Year Sharpe Ratio too high?
CanAlaska Uranium's current 1-Year Sharpe Ratio is -0.76. Overall, CanAlaska Uranium has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does CanAlaska Uranium's 1-Year Sharpe Ratio compare to competitors?
CanAlaska Uranium's 1-Year Sharpe Ratio of -0.76 can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Metals & Mining company?
A good 1-Year Sharpe Ratio depends on the Metals & Mining industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for CanAlaska Uranium and its competitors. CanAlaska Uranium's current 1-Year Sharpe Ratio is -0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanAlaska Uranium stock overvalued right now?
CanAlaska Uranium (FRA:DH7) has a current 1-Year Sharpe Ratio of -0.76. The current 1-Year Sharpe Ratio is -0.76. CanAlaska Uranium's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For CanAlaska Uranium (FRA:DH7), the current 1-Year Sharpe Ratio is -0.76 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CanAlaska Uranium Ltd is an explorer of uranium in the Athabasca Basin of Saskatchewan, Canada. It's a project generator model that the company has built a portfolio of uranium projects in the Athabasca Basin. The group owns numerous uranium properties, totaling approximately 500,000 hectares, with targets in the Athabasca Basin covering both basement and unconformity uranium deposit potential. The Company has recently concentrated on the West McArthur ultra-high-grade uranium expansion. It is focused on the discovery and delineation of Tier 1 uranium deposits in a safe and secure jurisdiction.
27GF Score
Get the complete analysis for FRA:DH7
1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DH7 has been successfully added to your 
